These results, along with a earlier report showing that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 support the principle of targeting ACKR3 as a unique solution to modulate the opioid program, which could open up new therapeutic avenues for opioid-connected disorders. Observe: Final results may possibly https://heinrichw157qvx2.bloggip.com/profile